Chromosomal loss of heterozygosity (LOH) is a common mechanism for the inactivation of tumor suppressor genes in human epithelial cancers. Hybridization to singlenucleotide polymorphism (SNP) arrays is an efficient method to detect genome-wide cancer LOH. Here, we survey LOH patterns in a panel of 33 human lung cancer cell lines using SNP array hybridization containing 1500 SNPs. We compared the LOH patterns generated by SNP array hybridization to those previously obtained by 399 microsatellite markers and find a high degree of concordance between the two methods. A novel informatics platform, dChipSNP, was used to perform hierarchical tumor clustering based on genome-wide LOH patterns. We demonstrate that this method can separate non-small-cell and small-cell lung cancer samples based on their shared LOH. Furthermore, we analysed seven human lung cancer cell lines using a novel 10 000 SNP array and demonstrate that this is an efficient and reliable method of high-density allelotyping. Using this array, we identified small regions of LOH that were not detected by lower density SNP arrays or by standard microsatellite marker panels.
Introduction
Lung cancer is the leading cause of cancer-related deaths in the United States (Jemal et al., 2003) . Its genetic basis is complex and involves several genetic alterations including activating mutations in proto-oncogenes (such as KRAS) and inactivation of tumor suppressor genes (Osada and Takahashi, 2002; Zabarovsky et al., 2002; Sekido et al., 2003) . Tumor suppressor gene inactivation typically requires two genetic events: a genetic deletion (loss of heterozygosity or LOH) on one of the chromosomal alleles and a smaller genetic event (such as a point mutation, promoter hypermethylation or a small intragenic deletion) on the other allele leading to biallelic inactivation of the gene.
LOH can be detected through allelotyping the DNA from a cancer sample and a corresponding normal control sample with polymorphic markers from each of the chromosomal arms. Traditionally, this involves polymerase chain reaction (PCR)-based amplification of simple sequence length polymorphisms (SSLPs) and the analysis of the amplified products using either gel-or capillary-based electrophoresis. Many studies in lung cancer have focused on LOH analyses in specific regions of the genome and correlated these findings with clinical outcome parameters including survival (Fong et al., 1994 (Fong et al., , 1995 Mitsudomi et al., 1996; Tseng et al., 1999) . However, given the genetic complexity of lung cancers, LOH events from multiple loci likely contribute to the overall phenotype of the tumor. Unbiased genome-wide analyses have also been performed, although most studies have used only a limited number of markers (Virmani et al., 1998; Stanton et al., 2000) . The most comprehensive genome-wide analysis in lung cancer using these methods was performed by Girard et al. (2000) , who studied a total of 36 lung cancer cell lines (14 small-cell lung cancer (SCLC) cell lines and 22 nonsmall-cell lung cancer (NSCLC) cell lines) using 399 fluorescent microsatellite markers This study provided a global estimate of LOH in both SCLC and NSCLC cell lines and identified several putative areas that may harbor previously undiscovered tumor suppressor genes.
Single-nucleotide polymorphisms (SNPs) are the most common form of sequence variation in the human genome, occurring approximately every 1200 base pairs (bps) (Sachidanandam et al., 2001; Reich et al., 2003) .
Owing to their frequency in the genome, they provide a high-density method for analyses of polymorphic markers, such as LOH. We and others have previously demonstrated that hybridization to SNP arrays provides an efficient and unbiased method to evaluate genomewide LOH from human tumors (Lindblad-Toh et al., 2000; Mei et al., 2000) . This method uses simultaneous PCR-based amplification of nearly 1500 genomic loci with hybridization to a high-density oligonucleotide array (Affymetrix HuSNP array). The HuSNP arrays are comparable to SSLP and comparative genomic hybridization in the ability to detect genome-wide LOH, with a reduction in the amount of time and DNA required to perform these analyses (Lindblad-Toh et al., 2000) . This method has the potential applicability in clinical and diagnostic laboratory setting and is ideally suited for the analysis of large numbers of tumor specimens. The HuSNP method has now been utilized by our group and other investigators to study allelic imbalances in primary human tumors, including samples generated by laser capture microdissection (Janne et al., 2002; Primdahl et al., 2002; Dumur et al., 2003; Hoque et al., 2003; Lieberfarb et al., 2003; Wang et al., 2003) . Recently, a high-density SNP array, Mapping 10K array, has been generated that can robustly and reproducibly analyse over 10 000 SNP loci using a genome representation approach (Kennedy et al., 2003) . This array has not been used previously to examine genome-wide LOH.
Genome-wide approaches such as mRNA expression profiling have led to the development of systematic tools for cancer classification (Eisen et al., 1998; Golub et al., 1999; Alizadeh et al., 2000) . We and other groups have performed expression profiling in lung cancer (Bhattacharjee et al., 2001; Garber et al., 2001; Beer et al., 2002) . Tumors from specific histologic subtypes (such as SCLC, adenocarcinoma or squamous cell carcinoma) were found to cluster together based on shared expression profiles using hierarchical clustering (Bhattacharjee et al., 2001; Garber et al., 2001) . Furthermore, among adenocarcinomas there are expression-based subgroups that associated with a shorter survival (Bhattacharjee et al., 2001; Garber et al., 2001; Beer et al., 2002) .
The dCHIP program (http://www.dchip.org), used in the analysis of gene expression data, has recently been modified (dChipSNP) to be able to analyse LOH data Lin et al., 2003) . The analysis of SNP arrays and other LOH data using dChipSNP now makes it possible to automate the detection of shared LOH regions and perform hierarchical clustering on tumors based on their shared LOH pattern . Previously, we have used these methods to analyse, perform hierarchical clustering and identify commonly deleted regions in prostate carcinoma specimens, and now apply them to lung carcinoma cell lines .
The present study was undertaken to characterize further and validate the efficacy of using the HuSNP array as a method for determining genome-wide LOH in lung cancer cell lines. The cell lines used in this study have all been characterized for LOH using SSLP markers (Girard et al., 2000) . We analysed the data generated by both the SNP and SSLP methods using the dChipSNP program . We demonstrate that clustering of LOH data can distinguish SCLC from NSCLC with reasonable accuracy. In addition, we provide data using the 10K SNP array (Affymetrix GeneChip s Mapping 10K Array Xba 130) and compare the LOH findings to HuSNP-and SSLP-based methods, noting that the higher density array permits the detection of smaller regions of LOH.
Results

Genome-wide LOH analysis of lung cancer cell lines using HuSNP arrays
We generated LOH profiles from the DNA of 33 lung cancer cell lines and their corresponding lymphoblastoid cell line controls using HuSNP arrays representing 1494 SNPs. The mean call rate was 80.3% and ranged from 71.6 to 86.2%. The average call rate did not vary significantly between the lymphoblastoid (82.274.3%) and tumor cell lines (80.374.5%). Markers numbers are summarized in Table 1 . The number of LOH events, the number of informative loci, the heterozygosity rate and the fractional allelic loss (FAL) are shown for all of the samples in Table 2 . The mean LOH% is similar between the SCLC and the NSCLC cell lines.
Virtual markers
In order to compare the data generated using HuSNPand SSLP-based methods, we generated virtual markers. Owing to the sparse nature of the HuSNP markers, this method allows us to infer a region of LOH based on the call (LOH or retention) of adjacent markers. We generated an LOH profile for each sample using virtual markers. The number of LOH events, the number of informative loci, the heterozygosity rate and the FAL are shown for all of the samples in Table 2 . There was a good correlation of sample-wise LOH percentage when we compared actual and virtual markers (R 2 ¼ 0.94; Supplemental Figure 1a) . We further applied the virtual marker method to the LOH data generated by SSLP and also found a good correlation between LOH data generated by actual and virtual markers (R 2 ¼ 0.95; Supplemental Figure 1b ). The total number of markers with known chromosomal positions are shown. The mean informative percentage is used to calculate the number of effective markers
Comparison of HuSNP-and SSLP-based methods
We compared the LOH data generated by the HuSNPand SSLP-based methods. As the SNP and SSLP markers are in different locations, we needed to use the virtual markers to compare LOH calls between the two methods, as the virtual markers generated from each data set are at the same chromosomal locations. After calculating LOH/retention calls for each virtual marker (total of 3025 markers Â 33 cell lines ¼ 99825), we examined the distribution of these calls using both the HuSNP and SSLP methods. A total of 51 888 virtual markers were informative in both array types. The LOH/retention call agreement was observed for 50 752 or 97.8% of the markers. We examined the regional concordance of the HuSNP-and SSLP-based methods by examining each chromosomal arm ( Figure 1 ). As can be seen in Figure 1 , there is a high rate of concordance of LOH between the two methods (also see supplemental Table 3 ) on p-and q-arms on all chromosomes (R 2 ¼ 0.96 for p-arms; R 2 ¼ 0.95 for q-arms). We also examined the samplewise LOH percentage correlation between HuSNP and SSLP using both actual and virtual markers (Supplemental Figure 1c and d) . In both cases, there was a good correlation between the two methods (R 2 ¼ 0.88 for actual markers and 0.89 for virtual markers). Additional comparisons between HuSNP-and SSLP-based methods are shown in supplemental Tables 1 and 2.
Sample clustering based on genome-wide LOH events
The dChipSNP program was used to perform sample clustering based on genome-wide LOH events. The The number of LOH events, the number of informative loci, the percent heterozygosity and the FAL are shown using both actual and virtual markers. The mean and standard deviations are shown separately for NSCLC and SCLC cell lines analysis was repeated for LOH data generated using SSLP. We examined three representative LOH score thresholds: 0.18, 0.22 and 0.46. Using the lowest threshold (0.18), the tumor cells cluster predominantly into SCLC and NSCLC based on their shared LOH (data not shown). However, the branch lengths are short and not well distinguished from the rest of the branches. As the threshold is increased to 0.22 and then to 0.46, we observe better separation of the sample branches ( Figure 2a ). However, with the higher threshold, three of the SCLC cell lines (HCC33, H1963 and H1672) now fall out of the main SCLC cluster and are clustered together with the NSCLCs. The large-cell carcinoma cell line H2126 even now clusters among the SCLC cell lines. Three main clusters become evident. The left branch contains mainly adenocarcinomas, the middle branch a combination of adenocarcinomas, other NSCLC and two SCLC cell lines (H1672 and HCC33) and the right branch predominately SCLC cell lines ( Figure 2a ). Hierarchical clustering of LOH data generated from the 33 cell lines using the SSLP-based methods was also performed using dChipSNP ( Figure 2b ). A cluster analysis with a threshold of 0.46 was also used and demonstrates similar separation of sample branches into three main clusters. However, there are some differences among the cells lines within each cluster. Similar to the HuSNP-based clustering, two of the SCLC cell lines (HCC33 and H1963) cluster among the NSCLC cell lines ( Figure 2b ). However, two adenocarcinoma cell lines (H1819 and H2087) cluster within the SCLC cell lines. We performed the analysis to determine whether these observed clustering results based on shared LOH are related to the histologic subtypes of the cell lines (SCLC vs NSCLC). We find that the 
LOH analysis using Mapping 10K SNP arrays
We analysed two control DNA specimens in duplicate and seven lung cancer cell lines with their corresponding lymphoblastoid cell lines using the GeneChip Mapping 10K array. The call rates for these samples are shown in Table 3 . The concordance rate between duplicate specimens was extremely high. The call rates were slightly higher for the normal cell lines compared to the tumor cell lines (94.2 vs 89.6%, respectively), but both were higher than those observed with the HuSNP array.
Comparison of LOH analyses using SSLP, HuSNP and Mapping 10K array methods
We compared the LOH calls generated by the HuSNP, SSLP and Mapping 10K arrays using seven cells lines and their control lymphoblastoid DNA. The number of LOH events, the number of informative loci, the heterozygosity rate and the FAL are shown for all of the samples in Table 4 . We also generated virtual markers (see Materials and methods) in order to be able to compare the three methods and performed similar analyses of LOH (Table 4) . For the seven cell lines, the total number of virtual markers analysed was 21175 (3025 virtual markers per cell line). The total number of virtual markers in common between HuSNP and Mapping 10K array was 12289. The rate of agreement in these markers between the two arrays was 98.5% (12100/12289 markers). For SSLP and 10K arrays, the number of virtual markers in common was 15 162, with The call rates and concordance between replicates for control DNA specimens are shown. The call rates, the mean and standard deviation are shown for seven tumor and corresponding normal lymphoblastoid cell lines We examined specific regions of the genome to determine if there are areas of LOH that were ambiguous or not identified by HuSNP and/or SSLP and could be identified using the Mapping 10K array due to the greater number of markers. Examples of these are shown in Figures 3 and 4 . LOH events were not identified on chromosome 10 using HuSNP analysis of sample pairs BL1648/H1648 and BL128/H128 (Figure 3) . By SSLP, each sample pair has one marker that demonstrates an LOH event. However, the adjacent markers are not informative and are separated by a significant genetic distance. Using the Mapping 10K array, small regions of LOH with a high density of informative loci were identified on chromosome 10 in both the cell lines (see circled section in Figure 3 ). The proximal and distal ends of the deletions are clearly identified and the single LOH events identified using SSLP fall within these regions. On chromosome 20, there is a single area of LOH identified by HuSNP in sample pair BL1648/H1648 (Figure 4) . The corresponding region using SSLP has four tandem LOH events, suggesting a deletion of 20q. This is confirmed using the 10K array, which demonstrates multiple contiguous deleted markers on 20q. The LOH events identified using HuSNP and SSLP fall within the region defined by the Mapping 10K array (circled regions in Figure 4) . We also examined the Mapping 10K SNP array data for regions of LOH that were not identified by either SSLP or HuSNP. Meaningful areas of deletion were defined as stretches of at least three contiguously deleted SNPs (Table 5 ). Multiple new small regions of LOH were identified using the Mapping 10K arrays in four out of the seven cell line pairs examined. We further compared the differences in the size of LOH regions detected by SSLP, HuSNP and the Mapping 10K array (Table 6 ) using these seven cell lines. The Mapping 10K array identified more than twice the number of LOH regions compared to SSLP or HuSNP. The minimum, mean and median sizes of these regions were substantially smaller Figure 3 The Mapping 10K array identifies regions of LOH that are missed by HuSNP. Blue, LOH; yellow, retention; gray, uninformative using the Mapping 10K array compared with the other two methods (Table 6 ). The maximum size of the LOH regions was similar with all three methods.
Discussion
The present study describes genome-wide LOH analyses of human lung cancer cell lines using SNP arrays. These same cell lines have been examined for LOH using 399 SSLP markers distributed throughout the entire genome (Girard et al., 2000) . We validated our SNP assay data by comparing it to the SSLP-based method with the aid of a novel informatics platform dChipSNP . Using these methods, we find a very high degree of concordance between the two types of LOH analyses as analysed by sample-wise LOH percentage or by chromosomal arm. By examining individual virtual markers, we find a 97.8% agreement between the two methods. The excellent agreement of the virtual marker calls using data from different platforms (SSLP and HuSNP) supports the validity of our method. Our results to date also represent the highest resolution of Figure 4 The Mapping 10K array helps define a region of LOH identified by either SSLP or HuSNP. Blue, LOH; yellow, retention; gray, uninformative allelotyping and most detailed analyses of individual loci in NSCLC and SCLC lung carcinoma cell lines using two independent methods. Hierarchical clustering approaches can be used to classify cancer samples using genome-wide approaches such as mRNA expression profiling. We now show that tumor classification can be performed by hierarchical clustering of LOH regions, using the dChipSNP software. Using this method, we are able to demonstrate that tumor cells lines cluster into three main groupings regardless of the method of LOH assessment. However, there are some minor differences among the individual cell lines within the clusters. The distribution of markers and the method of LOH assessment between SSLP and HuSNP likely account for these differences. We would expect even better cluster separation in studies using the Mapping 10K array. One of the groups contains predominately SCLC, another predominately adenocarcinoma cell lines and third a mixture of tumor cell lines. The large-cell carcinoma cell line H2126 clusters among the SCLC samples. Using mRNA expression profiling, large-cell tumors have also been found to cluster closest with SCLCs (Garber et al., 2001) .
Tumors bearing different LOH patterns may be more advanced or associated with different clinical behaviors (Hoque et al., 2003) . We did not analyse sufficient numbers of adenocarcinoma cell lines to be able to determine if there are several adenocarcinoma clusters based on shared LOH as has been demonstrated by shared mRNA expression (Bhattacharjee et al., 2001; Garber et al., 2001; Beer et al., 2002) . However, using HuSNP, we do find two clusters among the NSCLC cell lines and perhaps with greater numbers of samples additional groupings would be found. Interestingly, the cluster containing predominately adenocarcinomas (Figure 2a ) contains tumors cell lines with no LOH on chromosome 3, while the second NSCLC cluster contains tumors with LOH on chromosome 3. These findings also need to be validated in primary tumors and the significance of LOH patterns correlated with clinical outcome parameters. We have previously demonstrated that using laser capture microdissection we are able to isolate relative pure populations of tumor cells from paraffin-embedded specimens and perform HuSNP analyses (Janne et al., 2002; Lieberfarb et al., 2003) . Our pilot studies demonstrated that there was a significant difference in the mean LOH percentage between adenocarcinomas and bronchioloalveolar cell carcinomas (Janne et al., 2002) . Additional studies using paraffin-embedded tumor specimens and correlating the LOH patterns with clinical outcome(s) are underway. These techniques may ultimately also be more adaptable to clinical specimens compared with gene expression profiling as paraffin-embedded tumor specimens are more commonly available than fresh frozen tumor specimens.
Although the HuSNP method is higher throughput, faster and automated compared with SSLP-based analyses, neither method is perfect. The main disadvantage of the HuSNP method is the much lower rate of informative loci compared with SSLP-based methods (mean 22.3 vs 76.4%). Significant regions of the genome have few or no informative markers, thus limiting the utility of these approaches. Using both methods together, the combined informative rate is 84% and both methods provide calls for loci that were not informative by the other method (supplemental Tables 1  and 2 ). However, a combined analysis using both methods is unlikely to be practical for future studies.
Higher-density arrays would help overcome some of these limitations. The present study represents the first examination of the 10 000 SNP array. We have compared the results using the Mapping 10K array in seven cell lines both of which have also been examined using HuSNP and SSLP markers. We find approximately 10 times as many informative loci throughout the genome compared with HuSNP (Table 4 ). The Mapping 10K array also identifies 71.7 and 22.3% of the loci that were noninformative by HuSNP or SSLP, respectively (supplemental Tables 4-7) . With the increased resolution, smaller areas of deletions that are missed by HuSNP (see Figures 3 and 4) and areas of single LOH can now be further delineated. We also find several small areas of LOH and ones that were previously not identified using SSLP or HuSNP (Tables  5 and 6 ). Since the Mapping 10K array will aid significantly in the detection of small areas of LOH and provide the tools to begin isolating genes in such deletions, it should be the LOH detection method of choice for future studies.
Materials and methods
Tumor cell lines
In all, 33 lung cancer cell lines (14 SCLCs and 19 NSCLCs) and their normal matched lymphoblastoid cell lines were used in this study and have been characterized previously (Girard et al., 2000) . They were grown in cell culture in RPMI 1640 supplemented with 5 or 10% fetal bovine serum and DNA was prepared using standard methods.
HuSNP analyses
HuSNP analyses of normal and tumor cell DNA was performed according to previously published methods (Lindblad-Toh et al., 2000) . The primary PCR, using 24 pools of primer pairs, was performed using a total of 300 ng of DNA according to the manufacturer's recommendations. A 1 : 1000 dilution of each pool was reamplified using biotinylated T7 and T3 primers as described previously (Lindblad-Toh et al., 2000) . PCR products from each of the secondary pools were verified by using agarose-gel electrophoresis. Secondary PCR products were then concentrated (Microcon-10 spin column, Amicon Bioseparations, Bedford, MA, USA), denatured and hybridized to HuSNP arrays for 16 h at 441C and 40 r.p.m. The following day, the arrays were washed on the Affymetrix fluidics stations, stained with strepavidin-phycoerythrin and biotinylated-anti-strepavidin antibody, and scanned using the HP GeneArray Scanner (Hewlett-Packard, Palo Alto, CA, USA) all according to the manufacturer's recommended conditions (HuSNP Mapping Assay Manual, Affymetrix P/ N 700308) and as described previously (Lindblad-Toh et al.,  2000) .
GeneChip Mapping 10K array analyses
Preparation of DNA target DNA from tumor and control lymphoblastoid cell lines were prepared according to the Early Access Mapping Assay protocol as follows: DNA (250 ng) was digested with XbaI in 20 ml (New England Biolabs, Boston, MA, USA) and then ligated with a linker (supplied by Affymetrix, Inc.) by T4 DNA ligase (New England Biolabs, Boston, MA, USA) in a final volume of 25 ml. Four individual 100 ml mixtures were subsequently set up, containing 10 ml of 1 : 4 dilution of ligated DNA, 2.5 mM MgCl 2 , 250 mM dNTPs, 10 U Amplitaq Gold (PE Biosystems, Foster City, CA, USA) and 0.75 mM PCR primer (supplied by Affymetrix, Inc.). Mixtures were denatured for 3 min at 951C, followed by 35 cycles of 951C for 20 s, 591C for 15 s and 721C for 15 s, and a final extension of 721C for 7 min. The four PCR products were combined and concentrated using QIAquick columns (Qiagen, Inc.). Volumes were adjusted with distilled water to 47.5 ml containing 9-20 mg DNA.
Target labeling, hybridization, washing and staining The PCR products were fragmented by incubating them for 30 min at 371C, in a final volume of 55 ml containing 47.5 ml of the PCR products and DNAse (supplied by Affymetrix, Inc.). After fragmentation, 50 ml of this mixture was used to make a 65 ml labeling mixture, containing 0.0154 mM biotinylated-ddATP (Perkin-Elmer Life Sciences), 0.23-0.46 U (stock 15-30 U/ml) TdT (Promega) and incubated for 16 h at 371C, while the remaining 5 ml was examined for successful fragmentation using 4% NuSieve 3 : 1 plus agarose (Cambrex)-gel electrophoresis. The labeled DNA was diluted to a final volume of 240 ml containing 2.92 M tetramethylammonium chloride, 0.0125% Tween-20, 12.5 mg/ml Human Cot-1 DNA, 37.5 pM Oligo B2, 0.125 mg/ml herring sperm DNA, 6.25 mM EDTA, 2.71 Â Denhardt's solution, 5.4% DMSO, 0.061 M MES and denatured for 10 min at 951C. After 10 s on ice and 47.51C for 10 min, 200 ml of each sample was injected into the chips and hybridized for 16-18 h in a rotating oven (Affymetrix, Inc.) at 47.51C and 60 r.p.m. The following day, each array was washed and stained on the Affymetrix fluidics station. Arrays were first washed for six cycles with nonstringent Wash Buffer A (6Â SSPE (BioWhittaker Molecular Applications/ Cambrex) þ 0.01% Tween-20) at 251C and then for six cycles with stringent Wash Buffer B (0.6 Â SSPE, 0.01% Tween-20) at 451C. Arrays were subsequently incubated for 10 min at 251C using 10 mg/ml streptavidin (Pierce) in the Stain Buffer (6 Â SSPE, 0.01% Tween-20, 1 Â Denhardt's solution) in 500 ml, followed by washing for six cycles with nonstringent Wash Buffer A. Subsequently, the chips were stained for 10 min at 251C with 5 mg/ml biotinylated anti-streptavidin antibody (Vector Laboratories) in 500 ml of stain buffer and for 10 min at 251C with 10 mg/ml streptavidin, R-phycoerythrin conjugate (Molecular Probes) in 500 ml of stain buffer.
Scanning and allelotype generation The chips were scanned using the HP (Hewlett-Packard, Palo Alto, CA, USA) scanner according to the manufacturer's recommended conditions (HuSNP Mapping Assay Manual, Affymetrix P/N 700308). Hybridization signal was detected by Affymetrix Microarray Suite 5.0 software (Affymetrix, Inc.). Genotype calls were generated using the Genotyping Tools software. The data were analysed using the dChipSNP software .
Markers
In order to compare data generated by SSLP-and SNP-based methods, all markers were mapped into the UCSC hg13 genome assembly (http://genome.ucsc.edu/). When a marker was mapped to two or more genome positions, one position was randomly selected to use in the analyses. For the SNPbased methods, a minority of the SNPs in both the HuSNP and Mapping 10K arrays have not been mapped to any chromosomal location and are not included in the analyses. Using these criteria, the number of mapped markers and the number of effective markers (defined as the number of mapped markers times the mean heterozygosity) used in the analyses are shown in Table 1 .
LOH calls
For HuSNP and Mapping 10K array data, we used the Affymetrix genotyping software (Affymetrix GeneChip 5.0) to examine the SNP hybridization patterns and make SNP calls for all loci in each of the tumor cell lines and their corresponding lymphoblastoid cell lines. One of the three LOH calls are then assigned by dChipSNP for a loci in a pair of normal and tumor cell lines according to the following rules: L, loss (AB in normal, A or B in tumor); R, retention (AB in both normal and tumor); and N, noninformative or no call (AB_A or AB_B (implying either AB or A or B, respectively), or no call in normal or tumor). The overall call rate by the software was calculated as the number of SNPs assigned AA, BB or AB divided by the total number of SNPs in the array. For the 10K array, we calculated the concordance rate between duplicates specimens by only examining loci where an SNP assignment could be made. We calculated the heterozygosity rate by dividing the number of informative loci over the number of mapped markers for each of the specimens and by using either the SSLP-or SNP-based methods. FAL is defined as the number of LOH events divided by the total number of informative loci. We also obtained the LOH data generated using the SSLP-based methods and compared it to the SNP-based methods (Girard et al., 2000) . Since microsatellite alterations (MAs) cannot be evaluated using the SNPbased methods, we assigned a locus defined as LOH/MA as an L call, and those assigned as HET/MA as R calls. The dChipSNP software can then used to make LOH calls for the SSLP-based data.
Virtual markers
To account for the uneven marker distribution in the SNPbased analyses, we used 3025 virtual markers to cover the genome at 1 megabase (Mb) intervals. A 1 Mb distance was selected to balance the average between marker distance of 2 Mb in the HuSNP array and 300 Kb in the 10K array. The LOH calls of virtual markers are inferred by using 'Region with the same boundary, 10 Mb' method in the dChipSNP program . Using this method, we first declare a chromosomal region to have the 'same boundary' in one sample if there are two informative markers with the same L or R call on the two boundaries of the region, and there are no other informative markers in the region. Then, a virtual marker falling in such a region is inferred to have the same call as the boundaries, if the shorter distance between the virtual marker and the two boundaries is less than 10 Mb. Virtual markers are called as N if they do not fall in any regions with the same boundary. Thus, virtual markers between consecutive L or R calls are inferred as long as the distance between consecutive calls are smaller than 20 Mb. We also performed a more complicated statistical virtual marker inference method based on a hidden Markov model and obtained similar results (data not shown). Complete details of these methods are discussed and presented in full in Lin et al. (2003) .
We also inferred virtual markers for the data set generated by the SSLP-based method. The size of the PCR fragments ranged from 108 to 448 bps; thus we only considered their start positions when they were used to infer the LOH status for virtual markers at 1 Mb intervals.
Data generated with the virtual markers were then used to calculate the number of informative loci, the heterozygosity and the FAL as was carried out for the actual marker set. This was repeated for the data sets generated by the SNP-and SSLP-based methods. Furthermore, we examined the correlation between the rate of LOH obtained using the mapped actual markers and the virtual markers for each of the tumor cell lines using the data generated by both the SNP-and SSLPbased methods.
Sample clustering based on genome-wide LOH events
The dChipSNP program provides the ability to cluster tumor specimens based on their shared LOH regions. We computed an LOH score for virtual markers, if the weighted number of informative actual markers within 10 Mb on each side is X5. The score is the weighted LOH% across samples of the nearby actual markers and is between 0 and 1. A high LOH score indicates that many samples have LOH events in the nearby region.
This score is plotted on the right side of the LOH data picture in blue. By adjusting the score threshold line (in red), one can highlight (denoted by blue) the markers or genes in the chromosome regions with LOH scores exceeding the threshold. We define such regions as the selected chromosomal LOH regions.
The virtual markers in the above selected chromosomal LOH regions are used for sample clustering. The distance between two samples is defined as the ratio between the number of selected virtual markers having the same loss or retention call and the number of selected virtual markers informative in both samples. Average linkage is used for hierarchical clustering. Thus, if two samples share loss or retention of many chromosomal regions, they will cluster closely together.
By changing the LOH score threshold from 0.01 to 1.00, we can examine progressively 100 sample clustering trees. Using a larger threshold, the clustering is driven more by the regions with LOH events. This thresholding is similar to gene filtering in expression data; some regions with background noise are not used in the clustering and as a result this leads to better separation of cluster branches.
Comparison of LOH analysis using SSLP-and SNP-based methods LOH percentages determined by SSLP-and SNP-based methods were compared for each of the cell lines. We examined the correlation between the LOH percentage obtained by SSLP to that obtained by SNP and calculated an overall correlation coefficient. We repeated the analyses using both actual and virtual markers and calculated a correlation between the two methods over the whole genome. We also examined the LOH correlation for each of the chromosomal arms. We used the LOH calls generated for virtual markers to be able to compare the SNP-and SSLP-based methods. The percentage of LOH calls among informative virtual markers across all of the 33 samples are computed for the p-and q-arms separately and for the SNP-and SSLP-based methods separately. The p-arms were defined as a region from the beginning of a chromosome up to a defined chromosome position near the centromere and the q-arms were defined as a region from that defined position to the end of the chromosome (data not shown). These position points are based on the UCSC hg13 genome assembly file (cytoBand.txt).
Comparison of SNP LOH analysis using HuSNP and 10K array
We also analysed seven tumor cell lines, chosen at random, and their corresponding normal lymphoblastoid cell lines using the Gene Chip Mapping 10K array. These included two adenocarcinomas (H1395 and H1638) and five SCLC (H128, H2141, H289, H2107 and H2171) cell lines. The analysis of the number of LOH events and the rates of heterozygosity for both actual and virtual markers were analysed with the methods described for data generated with the HuSNP array. Using dChipSNP, we examined regions of LOH using the Mapping 10K array that were not identified using either HuSNP or SSLP. We defined a meaningful region of deletion as one that contained at least three contiguously deleted SNPs.
